Steven Cohen’s Edwards Lifesciences EW Stock Holding History

Steven Cohen’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$45.2K	Buy	+500	New	+$41.9K	﹤0.01%	3803
2026 Q1	–	Sell	-21,300	Closed	-$1.82M	–	3990
2025 Q4	$1.82M	Buy	21,300 +17,400	+446%	+$1.43M	﹤0.01%	2530
2025 Q3	$303K	Buy	3,900 +3,100	+388%	+$242K	﹤0.01%	2065
2025 Q2	$62.6K	Buy	+800	New	+$59.7K	﹤0.01%	2092
2024 Q2	–	Sell	-5,600	Closed	-$535K	–	2019
2024 Q1	$535K	Hold	5,600	–	–	﹤0.01%	1630
2023 Q4	$427K	Hold	5,600	–	–	﹤0.01%	1626
2023 Q3	$388K	Buy	+5,600	New	+$450K	﹤0.01%	1588

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Steven Cohen's EW Position: Q2 2026 in Review

Steven Cohen reduced its Edwards Lifesciences (EW) stake by 2.9% in Q2 2026, selling an estimated $4.39M and leaving 1,774,120 shares worth $160M. The position accounts for 0.18% of the portfolio, ranked #109.

Steven Cohen first reported a position in EW in Q3 2014 and has held it in 35 quarters since. The position peaked at $284M in Q1 2024. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Steven Cohen held 1,774,120 shares of Edwards Lifesciences worth $160M as of Q2 2026.
Steven Cohen sold 52,417 Edwards Lifesciences shares in Q2 2026, an estimated $4.39M.
Edwards Lifesciences made up 0.18% of Steven Cohen's portfolio in Q2 2026, its #109 holding.
Steven Cohen first reported a position in Edwards Lifesciences in Q3 2014 and has held it in 35 quarters since.
Steven Cohen's Edwards Lifesciences position peaked at $284M in Q1 2024.
1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.